Assessing Genomic Sequencing Information for Health Care Decision Making Workshop Summary (2014) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 81-96
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 81... ...
The recent revolution in genetic sequencing technology has led to an unprecedented opportunity to investigate the underlying etiology in families with genetic conditions, and yet it raises potential pitfalls that must be addressed in order to translate these new technologies into the practice of clinical genomics.
|
From page 82... ...
for Northern California Kaiser Permanente. He currently maintains a clinical practice in medical genetics at Kaiser Permanente Oakland.
|
From page 83... ...
He played a key role in coordinating NHGRI's activities related to family health history and was the planning chair for the NIH Consensus Development Program's 2009 State of the Science Conference "Family History and Improving Health." He also participated in efforts to help ensure the appropriate representation of family health history and genomic data in electronic health records. Additionally, as chief of the Genomic Healthcare Branch in the Office of the Director, he oversaw efforts to advance genomics education for health professional disciplines, including nurses, physician assistants, physicians, and pharmacists.
|
From page 84... ...
His work spans oncology, infectious diseases, cardiovascular disease, and metabolic disorders, and his research addresses the challenges for translating genomic information into medical practice using new and innovative paradigms and also examines the integration of personalized medicine into health care. He is an internationally recognized expert in genomics and personalized medicine with more than 200 published papers, and he has received funding from NIH, the Department of Defense, the Defense Advanced Research Projects Agency, the Bill & Melinda Gates Foundation, and industry.
|
From page 85... ...
Subsequently he pursued postdoctoral training in clinical cardiovascular medicine at Beth Israel Hospital and in molecular biology at Children's Hospital as a Bugher Foundation Fellow of the American Heart Association. Katrina Goddard, Ph.D., is a senior investigator at the Kaiser Permanente Northwest Center for Health Research in Portland, Oregon.
|
From page 86... ...
Study, funded by NIH, in which a cross-disciplinary team has conducted four separate multi-center randomized clinical trials, collectively enrolling 1,100 individuals to disclose a genetic risk factor for Alzheimer's disease in order to explore emerging themes in translational genomics.
|
From page 87... ...
The focus of her laboratory is to develop and perform comprehensive mutation analysis and interpretation for complex or challenging genetic disorders using multiple approaches. The primary focus of her clinical work is the development of high-throughput nextgeneration sequencing strategies for rare disorders using sequence capture technologies, robotics, clinical exome and genome sequencing, oligonucleotide array platforms, and robotics.
|
From page 88... ...
He served on a number of university committees including the executive faculty, committee on admissions, and the institutional review board. He previously worked in the palliative care program at Georgetown's Lombardi Cancer Center where he covered the gynecologic oncology service and he made home visits as a volunteer physician for a rural hospice on the Maryland Eastern Shore.
|
From page 89... ...
In his role at Washington University, Dr. Kulkarni oversees one of the most modern Clinical Laboratory Improvement Amendments–certified and College of American Pathologist– accredited state-of-the-art, full-service academic cytogenomics and molecular pathology laboratories in the country, which is currently staffed by more than 150 board-certified pathologists, clinical ge
|
From page 90... ...
She is an expert in the molecular pathology of genetic and infectious diseases and cancer and in policy development for genomic medicine.
|
From page 91... ...
Gary Lyman, M.D., M.P.H., is a practicing medical oncologist and is nationally and internationally recognized for his leadership in comparative effectiveness, health services, and outcomes research. He is a full member in the Cancer Prevention Program, Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, where he co-directs the Hutchinson Institute for Cancer Outcomes Research, a multidisciplinary team devoted to clinical and economic evaluations of new and existing cancer prevention, screening, and treatment technologies.
|
From page 92... ...
He performed residency and fellowship training at Walter Reed Army Medical center before coming to Memorial Sloan–Kettering in 1996. He is currently the clinic director of the Clinical Genetics Service and the immediate past chair of the Cancer Genetics Subcommittee of the Cancer Prevention Committee of the American Society of Clinical Oncology.
|
From page 93... ...
Dr. Saal has been at Cincinnati Children's Hospital Medical Center for 20 years, and his accomplishments have included establishing urban genetics outreach clinics in Hamilton County, developing the Cincinnati Children's Hereditary Cancer Program, and acting as director of the Craniofacial Center at Cincinnati Children's, where he continues to cultivate his interests in the care of children and families with genetic conditions and craniofacial disorders.
|
From page 94... ...
She is the author of more than 90 peer-reviewed articles. In her position at the forefront of consumer participation in genetics research, services, and policy, she serves in a leadership role on many of the major international and national organizations, including the IOM Health Sciences Policy Board, the National Coalition for Health Professional Education in Genetics board, and the International Rare Disease Research Consortium Interim Executive Committee, and is a member of the IOM Roundtable on Translating Genomic-Based Research for Health.
|
From page 95... ...
APPENDIX B 95 the Academy of Managed Care Pharmacy to develop guidelines and train decision makers in the practical application of cost-effectiveness models.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.